182 related articles for article (PubMed ID: 18798293)
1. Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy.
Hirschberg H; Uzal FA; Chighvinadze D; Zhang MJ; Peng Q; Madsen SJ
Lasers Surg Med; 2008 Oct; 40(8):535-42. PubMed ID: 18798293
[TBL] [Abstract][Full Text] [Related]
2. Age differences in photodynamic therapy-mediated opening of the blood-brain barrier through the optical clearing skull window in mice.
Zhang C; Feng W; Li Y; Kürths J; Yu T; Semyachkina-Glushkovskaya O; Zhu D
Lasers Surg Med; 2019 Sep; 51(7):625-633. PubMed ID: 30811633
[TBL] [Abstract][Full Text] [Related]
3. Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells.
Hirschberg H; Sun CH; Krasieva T; Madsen SJ
Lasers Surg Med; 2006 Dec; 38(10):939-45. PubMed ID: 17163479
[TBL] [Abstract][Full Text] [Related]
4. Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model.
Angell-Petersen E; Spetalen S; Madsen SJ; Sun CH; Peng Q; Carper SW; Sioud M; Hirschberg H
J Neurosurg; 2006 Jan; 104(1):109-17. PubMed ID: 16509154
[TBL] [Abstract][Full Text] [Related]
5. Increased nanoparticle-loaded exogenous macrophage migration into the brain following PDT-induced blood-brain barrier disruption.
Madsen SJ; Gach HM; Hong SJ; Uzal FA; Peng Q; Hirschberg H
Lasers Surg Med; 2013 Oct; 45(8):524-32. PubMed ID: 24037939
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin.
Hirschberg H; Zhang MJ; Gach HM; Uzal FA; Peng Q; Sun CH; Chighvinadze D; Madsen SJ
J Neurooncol; 2009 Dec; 95(3):317-329. PubMed ID: 19506813
[TBL] [Abstract][Full Text] [Related]
7. Cerebral edema following photodynamic therapy using endogenous and exogenous photosensitizers in normal brain.
Mathews MS; Chighvinadze D; Gach HM; Uzal FA; Madsen SJ; Hirschberg H
Lasers Surg Med; 2011 Nov; 43(9):892-900. PubMed ID: 22006731
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal photodynamic therapy in the Fischer 344 rat using 5-aminolevulinic acid and violet laser light: a toxicity study.
Major AL; Rose GS; Svaasand LO; Lüdicke F; Campana A; van Gemert MJ
J Photochem Photobiol B; 2002 Mar; 66(2):107-14. PubMed ID: 11897510
[TBL] [Abstract][Full Text] [Related]
9. Interstitial 5-ALA photodynamic therapy and glioblastoma: Preclinical model development and preliminary results.
Tetard MC; Vermandel M; Leroy HA; Leroux B; Maurage CA; Lejeune JP; Mordon S; Reyns N
Photodiagnosis Photodyn Ther; 2016 Mar; 13():218-224. PubMed ID: 26213327
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
van der Veen N; Hebeda KM; de Bruijn HS; Star WM
Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
[TBL] [Abstract][Full Text] [Related]
11. Assessment of safety of 5-aminolevulinic acid-mediated photodynamic therapy in rat brain.
Kimura S; Kuroiwa T; Ikeda N; Nonoguchi N; Kawabata S; Kajimoto Y; Ishikawa T
Photodiagnosis Photodyn Ther; 2018 Mar; 21():367-374. PubMed ID: 29414737
[TBL] [Abstract][Full Text] [Related]
12. Interstitial photodynamic therapy in subcutaneously implanted urologic tumors in rats after intravenous administration of 5-aminolevulinic acid.
Xiao Z; Tamimi Y; Brown K; Tulip J; Moore R
Urol Oncol; 2002; 7(3):125-32. PubMed ID: 12474546
[TBL] [Abstract][Full Text] [Related]
13. The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroids.
Mathews MS; Angell-Petersen E; Sanchez R; Sun CH; Vo V; Hirschberg H; Madsen SJ
Lasers Surg Med; 2009 Oct; 41(8):578-84. PubMed ID: 19731298
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of newly implanted glioma cells in the rat brain.
Madsen SJ; Angell-Petersen E; Spetalen S; Carper SW; Ziegler SA; Hirschberg H
Lasers Surg Med; 2006 Jun; 38(5):540-8. PubMed ID: 16392143
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of ultra short sub-30 minute incubation of 5-aminolevulinic acid photodynamic therapy in vitro.
Koo E; Austin E; Mamalis A; Jagdeo J
Lasers Surg Med; 2017 Aug; 49(6):592-598. PubMed ID: 28370019
[TBL] [Abstract][Full Text] [Related]
16. Low-fluence rate, long duration photodynamic therapy in glioma mouse model using organic light emitting diode (OLED).
Guo HW; Lin LT; Chen PH; Ho MH; Huang WT; Lee YJ; Chiou SH; Hsieh YS; Dong CY; Wang HW
Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):504-10. PubMed ID: 25936596
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive photodynamic therapy (PDT) for ablation of experimental rat glioma.
Hirschberg H; Spetalen S; Carper S; Hole P; Tillung T; Madsen S
Minim Invasive Neurosurg; 2006 Jun; 49(3):135-42. PubMed ID: 16921452
[TBL] [Abstract][Full Text] [Related]
18. Motexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids.
Madsen SJ; Mathews MS; Angell-Petersen E; Sun CH; Vo V; Sanchez R; Hirschberg H
J Neurooncol; 2009 Jan; 91(2):141-9. PubMed ID: 18777009
[TBL] [Abstract][Full Text] [Related]
19. Utility of the F98 rat glioma model for photodynamic therapy.
Madsen SJ; Kharkhuu K; Hirschberg H
J Environ Pathol Toxicol Oncol; 2007; 26(2):149-55. PubMed ID: 17725541
[TBL] [Abstract][Full Text] [Related]
20. ALA-PpIX mediated photodynamic therapy of malignant gliomas augmented by hypothermia.
Fisher CJ; Niu C; Foltz W; Chen Y; Sidorova-Darmos E; Eubanks JH; Lilge L
PLoS One; 2017; 12(7):e0181654. PubMed ID: 28759636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
